Literature DB >> 10811643

Translational control of the antiapoptotic function of Ras.

V A Polunovsky1, A C Gingras, N Sonenberg, M Peterson, A Tan, J B Rubins, J C Manivel, P B Bitterman.   

Abstract

Activated Ras has been shown to provide powerful antiapoptotic signals to cells through well defined transcriptional and post- translational pathways, whereas translational control as a mechanism of Ras survival signaling remains unexplored. Here we show a direct relationship between assembly of the cap-dependent translation initiation apparatus and suppression of apoptosis by oncogenic Ras in vitro and in vivo. Decreasing protein synthesis with rapamycin, which is known to inhibit cap-dependent translation, increases the susceptibility of Ras-transformed fibroblasts to cytostatic drug-induced apoptosis. In contrast, suppressing global protein synthesis with equipotent concentrations of cycloheximide actually prevents apoptosis. Enforced expression of the cap-dependent translational repressor, the eukaryotic translation initiation factor (eIF) 4E-binding protein (4E-BPI), sensitizes fibroblasts to apoptosis in a manner strictly dependent on its ability to sequester eIF4E from a translationally active complex with eIF4GI and the co-expression of oncogenic Ras. Ectopic expression of 4E-BP1 also promotes apoptosis of Ras-transformed cells injected into immunodeficient mice and markedly diminishes their tumorigenicity. These results establish that eIF4E-dependent protein synthesis is essential for survival of fibroblasts bearing oncogenic Ras and support the concept that activation of cap-dependent translation by extracellular ligands or intrinsic survival signaling molecules suppresses apoptosis, whereas synthesis of proteins mediating apoptosis can occur independently of the cap.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811643     DOI: 10.1074/jbc.M001938200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Defects in translational regulation mediated by the alpha subunit of eukaryotic initiation factor 2 inhibit antiviral activity and facilitate the malignant transformation of human fibroblasts.

Authors:  Darren J Perkins; Glen N Barber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

2.  Parkin modulates gene expression in control and ceramide-treated PC12 cells.

Authors:  P G Unschuld; J Dächsel; F Darios; A Kohlmann; E Casademunt; K Lehmann-Horn; M Dichgans; M Ruberg; A Brice; T Gasser; C B Lücking
Journal:  Mol Biol Rep       Date:  2006-03       Impact factor: 2.316

3.  Rapid turnover of mcl-1 couples translation to cell survival and apoptosis.

Authors:  Kenneth W Adams; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

Review 4.  Proapoptotic role of novel gene-expression factors.

Authors:  J V Tapia-Vieyra; P Ostrosky-Wegman; J Mas-Oliva
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.405

5.  eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.

Authors:  Shahram Khosravi; Kevin J Tam; Gholamreza S Ardekani; Magdalena Martinka; Kevin J McElwee; Christopher J Ong
Journal:  J Invest Dermatol       Date:  2015-01-06       Impact factor: 8.551

6.  Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.

Authors:  Shunan Li; Nahum Sonenberg; Anne-Claude Gingras; Mark Peterson; Svetlana Avdulov; Vitaly A Polunovsky; Peter B Bitterman
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

7.  mTOR-independent translational control of the extrinsic cell death pathway by RalA.

Authors:  Amith Panner; Jean L Nakamura; Andrew T Parsa; Pablo Rodriguez-Viciana; Mitchel S Berger; David Stokoe; Russell O Pieper
Journal:  Mol Cell Biol       Date:  2006-08-07       Impact factor: 4.272

8.  Transcriptional and translational control of ornithine decarboxylase during Ras transformation.

Authors:  Lisa M Shantz
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

9.  Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

Authors:  Konstantinos J Mavrakis; Hong Zhu; Ricardo L A Silva; John R Mills; Julie Teruya-Feldstein; Scott W Lowe; Wayne Tam; Jerry Pelletier; Hans-Guido Wendel
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.